FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

715 letters match. Newest first.

  1. Allovate Therapeutics, LLC

    FDA warned Allovate that its Allerdent allergenic toothpaste is an unapproved drug and lacks a required biologic license.

    High risk
  2. Health and Natural Beauty USA Corp.

    FDA warns Health and Natural Beauty USA over CGMP failures and unapproved, misbranded SprinJene OTC toothpastes, including children’s products.

    High risk
  3. Creative Essences, Inc.

    FDA warns Creative Essences over OTC drug manufacturing failures and an unapproved antiseptic.

    High risk
  4. New Life Medical Services, LLC

    FDA says New Life Medical Services sells unapproved umbilical-cord, amniotic-fluid, and exosome products as drugs.

    High risk
  5. Dixon Investments Inc. dba ARI

    FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.

    High risk
  6. Persōn & Covey, Inc.

    FDA cites Persōn & Covey for CGMP failures at its Glendale, CA drug plant and for selling unapproved Xerac AC and Drysol.

    High risk
  7. Pamela K. Den Besten, DDS, MS

    FDA warned sponsor-investigator Pamela K. Den Besten for running a pediatric dental gel study without an IND, enrolling 43 subjects.

    High risk
  8. Time Challenger Labs International, Inc.

    Time Challenger Labs was warned for unapproved drug claims on five supplements and serious manufacturing violations.

    High risk
  9. Stellalife, Inc.

    FDA told Stellalife its homeopathic oral care gels and rinses are unapproved new drugs sold without FDA approval.

    High risk
  10. PureRawz

    FDA warns PureRawz its tianeptine products are unapproved new drugs sold with drug claims.

    High risk
  11. cheaptrustedpharmacy.com

    cheaptrustedpharmacy.com sells unapproved, misbranded prescription drugs to U.S. consumers online, FDA warns.

    High risk
  12. Get.Fit.Medical, LLC dba Get.Fit.Medical

    FDA warned Get.Fit.Medical that its website sold compounded sildenafil, tadalafil, semaglutide and tirzepatide with false 'generic' claims.

    High risk
  13. FWD Care, Inc. dba FWD

    FDA warned telehealth company FWD Care that its website claims for compounded semaglutide and tirzepatide drugs are false or misleading.

    Medium
  14. Expert Aesthetics

    FDA warned Expert Aesthetics over website claims that its compounded semaglutide and tirzepatide are generic Ozempic and Mounjaro.

    Low
  15. Dermacare LLC dba BlueChew

    FDA warned BlueChew over website claims that its compounded sildenafil and tadalafil are the same as Viagra and Cialis.

    High risk
  16. Healthy Living Clinic

    FDA warned Healthy Living Clinic that its website misbrands compounded semaglutide by comparing it to Wegovy, Ozempic, and Rybelsus.

    Low
  17. Hims & Hers Health, Inc. dba Hers

    FDA warned Hims & Hers (Hers) that its website misleads consumers about compounded semaglutide by implying it is the same as approved Ozempic and Wegovy.

    Medium
  18. Amazing Meds

    FDA warned online seller Amazing Meds over unapproved compounded retatrutide and a misleading "same as Ozempic/Wegovy" semaglutide claim.

    High risk
  19. GenLabMeds

    GenLabMeds offered compounded retatrutide, semaglutide and tirzepatide online as unapproved, misbranded drugs with false or misleading claims.

    High risk
  20. ybycmeds

    FDA warns ybycmeds over website claims that compounded semaglutide and tirzepatide are similar to approved brand-name drugs.

    Medium
  21. iVisitDoc, Inc. dba iVisitDoc

    FDA warns iVisitDoc over website claims that compounded semaglutide is equivalent to Wegovy and Ozempic, calling the drugs misbranded.

    Medium
  22. Try Nova

    FDA warned Try Nova that its website’s compounded semaglutide claim "Same active ingredient as Wegovy & Ozempic" is false or misleading.

    Low
  23. The HCG Institute

    FDA warns The HCG Institute over misleading claims for compounded semaglutide sold online.

    High risk
  24. Vitals RX

    FDA warned telehealth seller Vitals RX that its website falsely implies compounded semaglutide and tirzepatide are the approved drug Ozempic.

    Medium
  25. Tuyo Health, Inc. dba Tuyo Health

    FDA warns Tuyo Health over misleading claims for compounded semaglutide and tirzepatide sold online.

    Medium
  26. Las Villas Health Care LLC dba Villas Health

    FDA warned Villas Health over website claims for compounded semaglutide and sildenafil, calling the drugs misbranded and unapproved.

    High risk
  27. JulyMD

    FDA warned JulyMD that its website sold compounded semaglutide with misleading claims comparing it to Wegovy and Ozempic.

    High risk
  28. Slendid

    FDA warned Slendid that its website sells compounded semaglutide and tirzepatide with a false "clinically proven" claim, making the drugs misbranded.

    Medium
  29. Hello Cake, Inc. dba Hello Cake

    FDA warns Hello Cake, an online telehealth seller, that its website misbrands compounded sildenafil and tadalafil ED drugs as equivalent to Viagra and Cialis.

    Medium
  30. Biopreventative Company LLC dba Biopreventative

    FDA told Biopreventative its website claim that compounded tadalafil is "commonly known as Cialis" misbrands the drug.

    Low
  31. Sprout Health Partners LLC dba Sprout Health

    FDA warned telehealth seller Sprout Health that its website's claim compounded semaglutide and tirzepatide are FDA-approved makes the drugs misbranded.

    Low
  32. Master Pharmaceuticals Group

    FDA warned Master Pharmaceuticals Group that its website sold compounded semaglutide and tirzepatide with false or misleading claims.

    High risk
  33. TRYM Health, Inc. dba TRYM Health

    FDA told telehealth seller TRYM Health its website claims for compounded semaglutide and tirzepatide are false and misleading, making the drugs misbranded.

    Medium
  34. HealBerry

    FDA warned HealBerry that claiming compounded semaglutide has the 'same active ingredient as Ozempic and Wegovy' misbrands its drugs.

    Medium
  35. Reset IV, LLC dba Reset IV

    FDA warned Reset IV that its website misbrands compounded semaglutide and tirzepatide by claiming they are the same as FDA-approved drugs.

    Medium
  36. SimpleRx

    FDA warned SimpleRx that its website falsely implied compounded semaglutide and tirzepatide were Ozempic or Zepbound.

    High risk
  37. Cosmo Medical Spa dba Cosmo Med Spa

    FDA warned Cosmo Med Spa over its website selling compounded semaglutide with claims implying it is FDA-approved Ozempic.

    Medium
  38. EvoLife Wellness

    FDA warned EvoLife Wellness that its website wrongly calls compounded semaglutide and tirzepatide "FDA-Approved," making the drugs misbranded.

    Medium
  39. eDrugstore

    FDA warns eDrugstore over claims that compounded tirzepatide is FDA-approved, making drugs misbranded (falsely promoted).

    High risk
  40. Nuvo Life Health Inc. dba Nuvo Life Health

    FDA warned Nuvo Life Health that its website sold compounded semaglutide and tirzepatide with misleading claims comparing them to FDA-approved drugs.

    Medium
  41. SemaBio

    FDA warned SemaBio that its website sold compounded semaglutide and called it 'generic semaglutide,' a false or misleading claim.

    Low
  42. Hims & Hers Health, Inc. dba Hims

    FDA warns Hims that compounded semaglutide website claims are false or misleading and misbrand the drugs.

    High risk
  43. Lumimeds

    FDA warns Lumimeds over website claims implying its compounded semaglutide and tirzepatide are FDA-approved.

    High risk
  44. GLP-1 Solution

    GLP-1 Solution sells unapproved compounded retatrutide online and misleadingly compares semaglutide and tirzepatide to FDA-approved brand drugs.

    High risk
  45. ASN-LABS

    ASN-LABS marketed unapproved compounded retatrutide and misleading semaglutide claims online, FDA says.

    High risk
  46. Body Good Studio

    FDA warned Body Good Studio over its website selling compounded semaglutide with a false claim that it matches Ozempic and Wegovy.

    High risk
  47. Canada Med Stop

    Canada Med Stop marketed compounded semaglutide online as FDA-approved and generic, making the drugs misbranded.

    Medium
  48. All American Wellness

    FDA warned telehealth seller All American Wellness that its website wrongly compares compounded semaglutide and tirzepatide to Ozempic and Mounjaro.

    Low
  49. Healthy Male

    FDA warns Healthy Male that its website sells compounded tirzepatide with false or misleading 'clinically proven' weight-loss claims.

    Low
  50. Intimate Rose

    FDA warned Intimate Rose that its website sells compounded semaglutide and tirzepatide with misleading claims that they match approved drugs.

    High risk